
July 1 (Reuters) - Baxter International Inc BAX.N:
FDA: AWARE THAT BAXTER ISSUED LETTER TO AFFECTED CUSTOMERS RECOMMENDING CERTAIN SPECTRUM INFUSION PUMPS BE REMOVED FROM WHERE THEY ARE USED OR SOLD
FDA: AS OF JUNE 12, BAXTER REPORTED NO SERIOUS INJURIES OR DEATHS ASSOCIATED WITH CERTAIN SPECTRUM INFUSION PUMPS ISSUE